Global female sexual dysfunction treatment market 2024-2028

Description

List of Tables

Technavio has been monitoring the female sexual dysfunction treatment market and is forecast to grow by USD 21691.6 million during 2023-2028, decelerating at a CAGR of 51.9% during the forecast period. Our report on the female sexual dysfunction treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, growing awareness of female sexual dysfunction, and approval and availability of drugs to treat hypoactive sexual desire disorder.

Technavio's female sexual dysfunction treatment market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Decelerate
YOY 2024	36.97%
CAGR	51.9%
Incremental Value	$21691.6million

By Age Group

Above 40 years
Below 40 years

By Product

Non-hormonal therapy
Hormonal therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing r and d for treatment of sexual dysfunction in women as one of the prime reasons driving the female sexual dysfunction treatment market growth during the next few years. Also, safety label changes for female sexual dysfunction therapy and increasing use of drugs causing sexual dysfunction in women will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the female sexual dysfunction treatment market covers the following areas:

Female sexual dysfunction treatment market sizing
Female sexual dysfunction treatment market forecast
Female sexual dysfunction treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading female sexual dysfunction treatment market vendors that include Assos Ilac, Cipla Inc., DARE BIOSCIENCE INC., Dr Reddys Laboratories Ltd., Duchesnay Inc., Endo International Plc, Freya Pharma Solutions B.V., Lupin Ltd., Mithra Pharmaceuticals SA, Novo Nordisk AS, Palatin Technologies Inc., Pfizer Inc., Pharmbio Korea Inc., Sprout Pharmaceuticals Inc., Strategic Science and Technologies LLC, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the female sexual dysfunction treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR70409

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Female Sexual Dysfunction Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Female Sexual Dysfunction Treatment Market 2018 - 2022 ($ million)
4.2 Age Group segment analysis 2018 - 2022
- Historic Market Size - Age Group Segment 2018 - 2022 ($ million)
4.3 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Age Group

6.1 Market segments
- Chart on Age Group - Market share 2023-2028 (%)
- Data Table on Age Group - Market share 2023-2028 (%)
6.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
6.3 Above 40 years - Market size and forecast 2023-2028
- Chart on Above 40 years - Market size and forecast 2023-2028 ($ million)
- Data Table on Above 40 years - Market size and forecast 2023-2028 ($ million)
- Chart on Above 40 years - Year-over-year growth 2023-2028 (%)
- Data Table on Above 40 years - Year-over-year growth 2023-2028 (%)
6.4 Below 40 years - Market size and forecast 2023-2028
- Chart on Below 40 years - Market size and forecast 2023-2028 ($ million)
- Data Table on Below 40 years - Market size and forecast 2023-2028 ($ million)
- Chart on Below 40 years - Year-over-year growth 2023-2028 (%)
- Data Table on Below 40 years - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
7.3 Non-hormonal therapy - Market size and forecast 2023-2028
- Chart on Non-hormonal therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Non-hormonal therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Non-hormonal therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Non-hormonal therapy - Year-over-year growth 2023-2028 (%)
7.4 Hormonal therapy - Market size and forecast 2023-2028
- Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
12.4 DARE BIOSCIENCE INC.
- DARE BIOSCIENCE INC. - Overview
- DARE BIOSCIENCE INC. - Product / Service
- DARE BIOSCIENCE INC. - Key offerings
12.5 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
12.6 Duchesnay Inc.
- Duchesnay Inc. - Overview
- Duchesnay Inc. - Product / Service
- Duchesnay Inc. - Key offerings
12.7 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
12.8 Freya Pharma Solutions B.V.
- Freya Pharma Solutions B.V. - Overview
- Freya Pharma Solutions B.V. - Product / Service
- Freya Pharma Solutions B.V. - Key offerings
12.9 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Product / Service
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
12.10 Mithra Pharmaceuticals SA
- Mithra Pharmaceuticals SA - Overview
- Mithra Pharmaceuticals SA - Product / Service
- Mithra Pharmaceuticals SA - Key offerings
12.11 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
12.12 Palatin Technologies Inc.
- Palatin Technologies Inc. - Overview
- Palatin Technologies Inc. - Product / Service
- Palatin Technologies Inc. - Key offerings
12.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.14 Sprout Pharmaceuticals Inc.
- Sprout Pharmaceuticals Inc. - Overview
- Sprout Pharmaceuticals Inc. - Product / Service
- Sprout Pharmaceuticals Inc. - Key offerings
12.15 Strategic Science and Technologies LLC
- Strategic Science and Technologies LLC - Overview
- Strategic Science and Technologies LLC - Product / Service
- Strategic Science and Technologies LLC - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations